OptiNose (OPTN) Stock Chart & Stock Price History → Elon Musk’s PRIME is Set to Shock the World (From InvestorPlace) (Ad) Free OPTN Stock Alerts $1.26 -0.03 (-2.33%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability OptiNose Stock Price Performance5 Day Performance+7.69%1 Month Performance+35.82%3 Month Performance-7.69%6 Month Performance+0.80%Year-To-Date Performance-2.33%1 Year Performance-29.61% Receive OPTN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OptiNose and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceElon Musk’s PRIME is Set to Shock the WorldMust-See: Elon's New Invention is Absolutely Insane When you click here and see what Elon Musk’s new invention does…You will NOT believe it. But Elon just tested this in a real human… And the result was mind-blowing.Click here for the full story… OPTN Stock Chart for Saturday, May, 18, 2024 OPTN Chart by TradingView OptiNose Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$1.29$1.26-2.33%$1.33$1.22899,255 shs$142.43 million05/16/2024$1.19$1.29+8.86%$1.31$1.16754,231 shs$145.82 million05/15/2024$1.13$1.19+4.87%$1.19$1.11568,954 shs$133.95 million05/14/2024$1.17$1.13-3.42%$1.17$1.05976,931 shs$127.73 million05/13/2024$1.22$1.17-4.10%$1.25$1.15659,322 shs$132.26 million05/10/2024$1.12$1.22+8.93%$1.24$1.12842,450 shs$137.91 million Get the Latest News and Ratings for OPTN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OptiNose and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$1.04$1.12+7.69%$1.18$1.001.57 million shs$126.60 million05/08/2024$1.03$1.04+0.97%$1.04$1.01220,015 shs$117.56 million05/07/2024$1.14$1.03-9.65%$1.15$1.01851,775 shs$116.43 million05/06/2024$1.01$1.14+12.87%$1.21$1.072.79 million shs$128.87 million05/03/2024$0.88$1.01+15.09%$1.01$0.881.10 million shs$114.17 million05/02/2024$0.91$0.88-3.37%$0.93$0.87514,378 shs$99.20 million05/01/2024$0.82$0.91+10.62%$0.92$0.82815,060 shs$102.66 million04/30/2024$0.86$0.82-4.45%$0.85$0.811.21 million shs$92.49 million04/29/2024$0.86$0.86-0.14%$0.88$0.831.37 million shs$96.79 million04/26/2024$0.91$0.86-4.93%$0.91$0.803.14 million shs$96.92 million04/25/2024$0.93$0.91-2.19%$1.25$0.8923.36 million shs$101.95 million04/24/2024$0.97$0.93-4.38%$0.96$0.89571,324 shs$104.24 million04/23/2024$1.03$0.97-6.05%$1.06$0.94671,563 shs$109.01 million04/22/2024$0.89$1.03+15.19%$1.05$0.861.26 million shs$116.03 million04/19/2024$0.93$0.89-3.61%$0.97$0.89653,099 shs$100.73 million04/18/2024$1.02$0.93-9.05%$1.03$0.92548,193 shs$104.51 million04/17/2024$1.09$1.02-6.42%$1.13$1.01461,327 shs$114.90 million04/16/2024$1.19$1.09-8.40%$1.19$1.09362,600 shs$122.79 million04/15/2024$1.22$1.19-2.46%$1.22$1.16508,955 shs$134.06 million04/12/2024$1.24$1.22-1.61%$1.25$1.16796,543 shs$137.43 million04/11/2024$1.25$1.24-0.80%$1.26$1.22615,835 shs$139.69 million04/10/2024$1.23$1.25+1.63%$1.25$1.20439,385 shs$140.82 million04/09/2024$1.33$1.23-7.52%$1.36$1.22350,815 shs$138.56 million04/08/2024$1.32$1.33+0.76%$1.35$1.30284,915 shs$149.82 million04/05/2024$1.37$1.32-3.65%$1.41$1.30377,720 shs$148.70 million04/04/2024$1.38$1.37-0.72%$1.40$1.34438,945 shs$154.33 million04/03/2024$1.41$1.38-2.13%$1.43$1.38233,597 shs$155.46 million04/02/2024$1.44$1.41-2.08%$1.47$1.40187,855 shs$158.84 million04/01/2024$1.46$1.44-1.37%$1.49$1.42492,460 shs$162.22 million03/29/2024$1.46$1.46$1.50$1.41399,834 shs$164.47 million03/28/2024$1.48$1.46-1.35%$1.50$1.41399,574 shs$164.47 million03/27/2024$1.48$1.48$1.49$1.43400,436 shs$166.72 million03/26/2024$1.50$1.48-1.33%$1.56$1.46443,253 shs$166.72 million03/25/2024$1.63$1.50-7.98%$1.64$1.46995,181 shs$168.98 millionMy #1 investment for 2024 (Ad)It’s something you use every single day and don’t even know it.Click here to see my #1 investment for 2024.03/22/2024$1.66$1.63-1.81%$1.68$1.57770,338 shs$183.62 million03/21/2024$1.72$1.66-3.21%$1.72$1.62431,559 shs$187.00 million03/20/2024$1.72$1.72-0.29%$1.76$1.621.55 million shs$193.20 million03/19/2024$1.94$1.72-11.11%$1.98$1.691.49 million shs$193.76 million03/18/2024$1.88$1.94+2.93%$2.10$1.764.25 million shs$217.98 million03/15/2024$1.90$1.87-1.58%$1.93$1.724.35 million shs$210.66 million03/14/2024$1.93$1.90-1.55%$1.92$1.85349,553 shs$214.04 million03/13/2024$1.90$1.93+1.85%$1.94$1.85504,346 shs$217.41 million03/12/2024$1.86$1.90+1.88%$1.91$1.83363,152 shs$213.47 million03/11/2024$1.68$1.86+10.71%$1.89$1.70797,249 shs$208.90 million03/08/2024$1.72$1.68-2.33%$1.77$1.64452,941 shs$188.68 million03/07/2024$1.75$1.72-1.71%$1.78$1.62384,834 shs$193.17 million03/06/2024$1.73$1.75+1.45%$1.79$1.72310,082 shs$196.54 million03/05/2024$1.73$1.73-0.29%$1.77$1.66316,748 shs$193.74 million03/04/2024$1.91$1.73-9.42%$1.94$1.67653,931 shs$194.30 million03/01/2024$1.78$1.91+7.30%$1.91$1.77471,365 shs$214.51 million02/29/2024$1.82$1.78-1.93%$1.86$1.74378,099 shs$199.91 million02/28/2024$1.69$1.82+7.40%$1.85$1.70969,326 shs$203.84 million02/27/2024$1.65$1.69+2.42%$1.75$1.60553,186 shs$189.80 million02/26/2024$1.56$1.65+5.77%$1.71$1.58554,329 shs$185.32 million02/23/2024$1.47$1.56+6.12%$1.69$1.48911,845 shs$175.20 million02/22/2024$1.34$1.47+9.70%$1.51$1.351.06 million shs$165.10 million02/21/2024$1.36$1.34-1.47%$1.39$1.33193,879 shs$150.50 million02/20/2024$1.37$1.36-0.37%$1.42$1.36208,956 shs$152.74 million02/19/2024$1.37$1.37$1.38$1.33184,000 shs$153.30 million Related Companies: Context Therapeutics Stock Price Chart Amylyx Pharmaceuticals Stock Price Chart Karyopharm Therapeutics Stock Price Chart PDS Biotechnology Stock Price Chart Nuvectis Pharma Stock Price Chart Cartesian Therapeutics Stock Price Chart Vistagen Therapeutics Stock Price Chart DiaMedica Therapeutics Stock Price Chart Coya Therapeutics Stock Price Chart Seres Therapeutics Stock Price Chart Receive OPTN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for OptiNose and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OPTN) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaObama’s Forever Term [exposed]Porter & Company4 Cryptos BETTER than BitcoinTrue Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressProtect Your Bank Account Before It’s Too LateWeiss RatingsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptiNose, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.